Annual Current Liabilities
$145.48 M
+$46.04 M+46.30%
31 December 2023
Summary:
ANI Pharmaceuticals annual total current liabilities is currently $145.48 million, with the most recent change of +$46.04 million (+46.30%) on 31 December 2023. During the last 3 years, it has risen by +$66.91 million (+85.17%). ANIP annual current liabilities is now -12.12% below its all-time high of $165.55 million, reached on 31 December 2018.ANIP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$189.93 M
+$49.95 M+35.69%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly total current liabilities is currently $189.93 million, with the most recent change of +$49.95 million (+35.69%) on 30 September 2024. Over the past year, it has increased by +$55.58 million (+41.37%). ANIP quarterly current liabilities is now at all-time high.ANIP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.3% | +41.4% |
| 3 y3 years | +85.2% | +123.8% |
| 5 y5 years | -12.1% | +11.3% |
ANIP Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +85.2% | at high | +138.8% |
| 5 y | 5 years | -12.1% | +135.9% | at high | +207.9% |
| alltime | all time | -12.1% | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $189.93 M(+35.7%) |
| June 2024 | - | $139.98 M(+2.3%) |
| Mar 2024 | - | $136.89 M(-5.9%) |
| Dec 2023 | $145.48 M(+46.3%) | $145.48 M(+8.3%) |
| Sept 2023 | - | $134.35 M(+9.3%) |
| June 2023 | - | $122.86 M(-2.4%) |
| Mar 2023 | - | $125.83 M(+26.5%) |
| Dec 2022 | $99.44 M(+13.6%) | $99.44 M(+21.8%) |
| Sept 2022 | - | $81.63 M(-15.2%) |
| June 2022 | - | $96.31 M(+21.1%) |
| Mar 2022 | - | $79.53 M(-9.1%) |
| Dec 2021 | $87.54 M(+11.4%) | $87.54 M(+3.1%) |
| Sept 2021 | - | $84.87 M(-5.1%) |
| June 2021 | - | $89.45 M(+8.1%) |
| Mar 2021 | - | $82.77 M(+5.3%) |
| Dec 2020 | $78.56 M(+27.4%) | $78.56 M(+3.5%) |
| Sept 2020 | - | $75.90 M(-4.0%) |
| June 2020 | - | $79.09 M(-0.3%) |
| Mar 2020 | - | $79.36 M(+28.7%) |
| Dec 2019 | $61.68 M(-62.7%) | $61.68 M(-63.9%) |
| Sept 2019 | - | $170.71 M(+2.3%) |
| June 2019 | - | $166.79 M(+1.0%) |
| Mar 2019 | - | $165.07 M(-0.3%) |
| Dec 2018 | $165.55 M(+322.0%) | $165.55 M(+253.0%) |
| Sept 2018 | - | $46.90 M(+18.2%) |
| June 2018 | - | $39.68 M(+0.1%) |
| Mar 2018 | - | $39.65 M(+1.1%) |
| Dec 2017 | $39.23 M(+22.8%) | $39.23 M(+7.8%) |
| Sept 2017 | - | $36.38 M(+28.6%) |
| June 2017 | - | $28.29 M(-12.7%) |
| Mar 2017 | - | $32.42 M(+1.5%) |
| Dec 2016 | $31.95 M(+171.8%) | $31.95 M(+4.8%) |
| Sept 2016 | - | $30.49 M(+23.3%) |
| June 2016 | - | $24.73 M(+52.6%) |
| Mar 2016 | - | $16.21 M(+37.9%) |
| Dec 2015 | $11.76 M(-11.2%) | $11.76 M(-3.6%) |
| Sept 2015 | - | $12.19 M(+75.4%) |
| June 2015 | - | $6.95 M(-23.4%) |
| Mar 2015 | - | $9.07 M(-31.4%) |
| Dec 2014 | $13.23 M(+274.0%) | $13.23 M(+62.5%) |
| Sept 2014 | - | $8.14 M(+112.8%) |
| June 2014 | - | $3.83 M(-16.1%) |
| Mar 2014 | - | $4.56 M(+28.9%) |
| Dec 2013 | $3.54 M(-66.6%) | $3.54 M(-46.4%) |
| Sept 2013 | - | $6.60 M(+7.0%) |
| June 2013 | - | $6.16 M(-33.9%) |
| Mar 2013 | - | $9.33 M(-12.0%) |
| Dec 2012 | $10.59 M | $10.59 M(-3.0%) |
| Sept 2012 | - | $10.92 M(-33.3%) |
| June 2012 | - | $16.37 M(+169.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $6.08 M(-15.8%) |
| Dec 2011 | $7.23 M(-11.7%) | $7.23 M(-37.1%) |
| Sept 2011 | - | $11.50 M(+0.2%) |
| June 2011 | - | $11.48 M(-9.1%) |
| Mar 2011 | - | $12.63 M(+54.4%) |
| Dec 2010 | $8.18 M(+108.2%) | $8.18 M(+15.3%) |
| Sept 2010 | - | $7.10 M(+6.1%) |
| June 2010 | - | $6.69 M(+7.5%) |
| Mar 2010 | - | $6.22 M(+58.4%) |
| Dec 2009 | $3.93 M(+2.0%) | $3.93 M(-17.7%) |
| Sept 2009 | - | $4.78 M(+28.5%) |
| June 2009 | - | $3.72 M(+19.7%) |
| Mar 2009 | - | $3.10 M(-19.4%) |
| Dec 2008 | $3.85 M(+154.2%) | $3.85 M(-15.7%) |
| Sept 2008 | - | $4.57 M(+26.2%) |
| June 2008 | - | $3.62 M(+23.7%) |
| Mar 2008 | - | $2.93 M(+93.1%) |
| Dec 2007 | $1.52 M(-64.7%) | $1.52 M(-32.2%) |
| Sept 2007 | - | $2.23 M(-14.4%) |
| June 2007 | - | $2.61 M(+7.4%) |
| Mar 2007 | - | $2.43 M(-43.5%) |
| Dec 2006 | $4.30 M(+61.3%) | $4.30 M(+158.5%) |
| Sept 2006 | - | $1.66 M(-27.8%) |
| June 2006 | - | $2.30 M(-15.8%) |
| Mar 2006 | - | $2.73 M(+2.6%) |
| Dec 2005 | $2.67 M(+39.8%) | $2.67 M(+77.2%) |
| Sept 2005 | - | $1.50 M(-3.0%) |
| June 2005 | - | $1.55 M(-14.4%) |
| Mar 2005 | - | $1.81 M(-5.0%) |
| Dec 2004 | $1.91 M(+116.4%) | $1.91 M(+42.7%) |
| Sept 2004 | - | $1.34 M(+13.6%) |
| June 2004 | - | $1.18 M(+2.6%) |
| Mar 2004 | - | $1.15 M(+30.1%) |
| Dec 2003 | $881.20 K(-29.9%) | $881.20 K(+25.9%) |
| Sept 2003 | - | $700.10 K(-2.8%) |
| June 2003 | - | $720.60 K(+29.9%) |
| Mar 2003 | - | $554.90 K(-55.8%) |
| Dec 2002 | $1.26 M(+35.4%) | $1.26 M(+81.3%) |
| Sept 2002 | - | $692.80 K(-5.8%) |
| June 2002 | - | $735.70 K(+8.5%) |
| Mar 2002 | - | $678.20 K(-26.9%) |
| Dec 2001 | $927.80 K(-1.4%) | $927.80 K(-9.8%) |
| Sept 2001 | - | $1.03 M(+9.4%) |
| June 2001 | - | $940.70 K(+18.4%) |
| Mar 2001 | - | $794.50 K(-15.6%) |
| Dec 2000 | $941.30 K(+186.0%) | $941.30 K(+35.0%) |
| Sept 2000 | - | $697.30 K(+182.1%) |
| June 2000 | - | $247.20 K(-13.7%) |
| Mar 2000 | - | $286.30 K |
| Dec 1999 | $329.10 K(-59.8%) | - |
| Dec 1998 | $817.90 K | - |
FAQ
- What is ANI Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual current liabilities year-on-year change?
- What is ANI Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly current liabilities year-on-year change?
What is ANI Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ANIP is $145.48 M
What is the all time high annual current liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total current liabilities is $165.55 M
What is ANI Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ANIP annual total current liabilities has changed by +$46.04 M (+46.30%)
What is ANI Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ANIP is $189.93 M
What is the all time high quarterly current liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total current liabilities is $189.93 M
What is ANI Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ANIP quarterly total current liabilities has changed by +$55.58 M (+41.37%)